Syngene International Limited’s Post

Informist Newswire has featured Syngene in an industry article titled "Indian CDMO companies must level up for opportunity from US Biosecure Act," highlighting the potential impact of the Biosecure Act on pharmaceutical supply chains. The article mentions that global pharma companies are increasingly turning to Indian CRDMOs like Syngene to diversify their supply chains, attracted by India's focus on innovation, advanced technology adoption, and strong quality track records. Read the full article, link in the comments section 🔗 #CRDMO #BiosecureAct

It is becoming increasingly important to explore alternative markets for diversification of your supply chain. Let’s discuss how Syngene can assist you with those goals.

What does the future of drug manufacturing look like? What can a CDMO do to  manage the quickly changing landscape of pharmaceuticals? In this Endpoints News webinar, Alessandro Maselli, CEO of Catalent Pharma Solutions, talks with editor John Carroll about: -- Stability, trust and growth management that come from working with CDMOs -- What’s changing in the CDMO industry (consolidation, innovations, NDAs) -- The effect of “reshoring” from Asia to the US and/or Europe, thanks to the BIOSECURE Act and other factors At Ritedose, we can help you manage growth and deal with the changing CDMO climate! Watch the webinar recording: https://lnkd.in/e7z6BP6u

Get an insider’s view of the Indian pharma industry with Entod Pharmaceuticals. In this video, Entod CEO Nikkhil K Masurkar lays out his vision for Indian pharmaceutical innovation—and how Entod’s presence in this landscape, including their innovative treatments in rare eye conditions and more, fit into it. From a grassroots movement in R&D and beyond, Mr. Masurkar explains how India is aiming to lead the world in moving towards a competitive, research-driven ecosystem—and what a difference that could make for patients and practitioners on the world stage. Check out the video for all the details, and visit Entod’s website at www.entodpharma.com for more. #entodpharma #conference #eyecare #MediaMICE

Get an insider’s view of the Indian pharma industry with Entod Pharmaceuticals. In this video, Entod CEO Nikkhil K Masurkar lays out his vision for Indian pharmaceutical innovation—and how Entod’s presence in this landscape, including their innovative treatments in rare eye conditions and more, fit into it. From a grassroots movement in R&D and beyond, Mr. Masurkar explains how India is aiming to lead the world in moving towards a competitive, research-driven ecosystem—and what a difference that could make for patients and practitioners on the world stage. Check out the video for all the details, and visit Entod’s website at www.entodpharma.com for more. #entodpharma #conference #eyecare #MediaMICE

Ready to face the changing #inhaled and #nasal #drugdelivery industry? With a growing biologics market and an evolving regulatory landscape, modern-day inhaled and nasal drug product development is a balancing act. Against this changing backdrop, CDMOs with specialist knowledge and expertise have a crucial role to play in helping pharma companies chart the best route forward. In the latest issue of PMPS, our experts show you what best practices look like in drug-device development, as well as what you should look for in a CDMO partner. Read the article to explore our team’s insights: https://lnkd.in/eTb6Sx6i #Bespak #Sustainability #Pharma #InhalationDevices #pMDI #ClimatefriendlyPropellants #DrugDelivery #CDMO

We’re back with another episode of Scimplify’s webinar series #MoleculeMakers – Innovating for a Sustainable Future. 🌿 Dive into this session with our esteemed guest Prof Javed Iqbal – Ex-Director, Dr. Reddy's Institute of Life Sciences, and our host Karthik Kumar – Head of the Pharmaceutical Division at Scimplify to explore the critical roles that CDMOs like Scimplify play in pharmaceutical industry. 🔊   The episode titled 𝐌𝐚𝐱𝐢𝐦𝐢𝐳𝐢𝐧𝐠 𝐏𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐯𝐢𝐭𝐲 & 𝐒𝐜𝐚𝐥𝐚𝐛𝐢𝐥𝐢𝐭𝐲 – 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐜 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐟𝐨𝐫 𝐂𝐃𝐌𝐎𝐬 will drive discussions on innovative strategies for enhancing scalability and productivity to navigate the challenges and opportunities in the ever-evolving #Pharmaceutical landscape. 💊 👉 Reserve your spot: https://shorturl.at/dKDJ3 📆 9th August, 2024 ⏰ 4:00 PM - 5:00 PM Looking forward to your participation in what promises to be an enlightening discussion. Sounds exciting? Reserve your spot now! 🔺 . . . #CDMO #PharmaceuticalManufacturing #PharmaceuticalIndustry #StrategicInsights #SpecialtyChemicals #WebinarSeries

Get an insider’s view of the Indian pharma industry with Entod Pharmaceuticals. In this video, Entod CEO Nikkhil K Masurkar lays out his vision for Indian pharmaceutical innovation—and how Entod’s presence in this landscape, including their innovative treatments in rare eye conditions and more, fit into it. From a grassroots movement in R&D and beyond, Mr. Masurkar explains how India is aiming to lead the world in moving towards a competitive, research-driven ecosystem—and what a difference that could make for patients and practitioners on the world stage. Check out the video for all the details, and visit Entod’s website at www.entodpharma.com for more. #entodpharma #conference #eyecare #MediaMICE

Get the scoop on Indian pharma with Entod’s CEO, Nikkhil K Masurkar! He talks innovation, rare eye treatments, and how India’s set to lead the global scene. Curious? Watch the video for all the details.

AI in Pharmaceutical Industry: Moving from Hype to Reality. Have a look at McKinsey Global BCG's report on AI adoption by Big Pharma. #McKinseyCompany #Pharma #CRO #AI #GenerativeAI #LifeSciences #DrugDiscovery